#ASCO2017 – Abiraterone for Prostate Cancer
5 Jun, 2017 | 14:51h | UTC#ASCO2017 – Abiraterone for Prostate Cancer
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer – New England Journal of Medicine (free) AND Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy – New England Journal of Medicine (free)
ASCO News Releases: Abiraterone Delays Metastatic Prostate Cancer Growth by 18 Months, Extends Survival (free) Abiraterone Slows Advanced Prostate Cancer, Helps Patients Live Longer (free)